2020
DOI: 10.1016/j.oraloncology.2019.104522
|View full text |Cite
|
Sign up to set email alerts
|

Distinct biomarker and behavioral profiles of human papillomavirus-related oropharynx cancer patients by age

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
17
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 21 publications
(17 citation statements)
references
References 25 publications
0
17
0
Order By: Relevance
“…10,11 Another potential component of HPV-OPC risk described in this analysis is a novel measure of sexual intensity (measured by sex-years, a calculation of the number of oral sex partners per 10 years across different ages). 18 Similar to how pack-years describes tobacco history and drink-years characterizes alcohol use, 19 the new metric of sex-years characterizes cumulative sexual exposure over time as a surrogate for potential exposure to HPV. Our data suggest that higher concentration and intensity of partner exposure is an independent predictor of HPV-OPC risk, as evidenced by an association of increased sexyears with HPV-OPC even after adjusting for number of oral sex partners.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…10,11 Another potential component of HPV-OPC risk described in this analysis is a novel measure of sexual intensity (measured by sex-years, a calculation of the number of oral sex partners per 10 years across different ages). 18 Similar to how pack-years describes tobacco history and drink-years characterizes alcohol use, 19 the new metric of sex-years characterizes cumulative sexual exposure over time as a surrogate for potential exposure to HPV. Our data suggest that higher concentration and intensity of partner exposure is an independent predictor of HPV-OPC risk, as evidenced by an association of increased sexyears with HPV-OPC even after adjusting for number of oral sex partners.…”
Section: Discussionmentioning
confidence: 99%
“…Serum was obtained before initiation of treatment and tested for antibodies to E6 and E7 for oncogenic HPV types 16,18,31,33,35,45,52, and 58 and E1, E2, E4 for HPV types 16 and 18 at the German Cancer Research Center (Heidelberg, Germany). In brief, multiplex serology, an antibody detection method based on glutathione S-transferase capture enzymelinked immunosorbent assay was used in combination with fluorescent bead-based technology.…”
Section: Specimen Testingmentioning
confidence: 99%
“…Mounting evidence has shown an increase in older population in HPV‐positive NMSC [41–43]. Distribution of HPV16 among HPV‐positive oropharynx squamous cell cancer also differs by age group [44]. As for melanoma, a previous study revealed several differences exist in risk factors such as family history, UV exposure, and sunburn history between young adults and middle‐aged patients [45].…”
Section: Discussionmentioning
confidence: 99%
“…Importantly, one of the key supportive arguments for the utilization of reduced-dose radiotherapy in HPV-positive OPSCC patients is to avoid the long-term toxicities in younger, medically fit patients [18]. The lack of a significant age discrepancy between the two subgroups may be an example of the increasing prevalence of HPV-positive OPSCC's amongst older cohorts also [19].…”
Section: Discussionmentioning
confidence: 99%